Spleen tyrosine kinase inhibitor R406 has both antiviral and anti‐inflammatory effects on severe influenza A infection

Junhao Luo(National Institute for Viral Disease Control and Prevention), Rongbao Gao(National Institute for Viral Disease Control and Prevention)
Journal of Medical Virology
May 1, 2024
Cited by 3


Related Papers